港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

来凯医药-B

16.240

-0.420-2.52%

成交量：908.60万

成交额：1.49亿

市值：66.26亿

市盈率：-20.97

高：17.390

开：17.000

低：15.900

收：16.660

52周最高：23.500

52周最低：4.200

股本：4.08亿

香港流通股本：4.08亿

量比：3.03

换手率：2.23%

股息：- -

股息率：- -

每股收益(LYR):-0.774

净资产收益率：-34.59%

总资产收益率：-19.92%

市净率：8.53

市盈率(LYR):-20.97

市销率: 1314.83

数据加载中...

总览公司新闻公告

每日卖空追踪 | 来凯医药-B 06月25日卖空量成交2.1万股，卖空比例为0.26%

来凯医药-B盘中异动早盘快速下挫5.08%报18.700港元

医药行业周专题：减重需求正盛多方向酝酿破局

2025年医药行业动态与战略布局：创新药物研发驱动市场增长

来凯医药-B高开逾8% 于ADA 2025大会上公布包含LAE102等多项临床研究结果

截至6月24日来凯医药、泰凌微电子、生益电子、华工科技等重点公司的公告

刘翔科技研究

生物医药：体内CAR-T：全球竞赛已打响，关注云顶新耀和石药集团

每日卖空追踪 | 来凯医药-B 06月23日卖空量成交5000股，卖空比例为0.04%

来凯医药-B盘中异动早盘急速跳水5.04%报19.800港元

来凯医药-B：LAE102、LAE103及LAE123临床和临床前研究结果在2025年ADA大会上公布

来凯医药-B06月20日主力净流入30.4万元散户资金抛售

【热门行业】中国创新药估值逻辑加速重构行业或进入2-3年上行期

背景资料-要脂肪，不要肌肉制药商竞相寻求下一个减肥突破

每日卖空追踪 | 来凯医药-B 06月18日卖空量成交12.7万股，卖空比例为3%

每日卖空追踪 | 来凯医药-B 06月17日卖空量成交3.5万股，卖空比例为0.36%

每日卖空追踪 | 来凯医药-B 06月16日卖空量成交6.95万股，卖空比例为1.03%

来凯医药-B盘中异动早盘股价大涨5.19%

每日卖空追踪 | 来凯医药-B 06月13日卖空量成交3.75万股，卖空比例为0.56%

来凯医药-B盘中异动急速下挫5.02%

6.5亿美元！礼来押注AI平台，开发“增肌”新药

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02105/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"来凯医药-B","latestPrice":16.24,"timestamp":1756195699001,"preClose":16.66,"halted":0,"volume":9086000,"delay":0,"floatShares":408000000,"shares":408000000,"eps":-0.774437652950583,"marketStatus":"已收盘","change":-0.42,"latestTime":"08-26 16:08:19","open":17,"high":17.39,"low":15.9,"amount":148510298,"amplitude":0.089436,"askPrice":16.24,"askSize":268000,"bidPrice":16.2,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.7122672995046607,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":16.66,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":3.025278,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":408000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.774438,"volumeRatio":3.025278,"shares":408000000,"dividePrice":0,"high":17.39,"amplitude":0.089436,"preClose":16.66,"low":15.9,"week52Low":4.2,"pbRate":"8.53","psRate":"1314.83","week52High":23.5,"institutionHeld":0,"latestPrice":16.24,"committee":-0.988868,"eps":-0.774437652950583,"divideRate":0,"volume":9086000,"delay":0,"ttmEps":-0.7122672995046607,"open":17,"prevYearClose":9.37,"prevWeekClose":17.19,"prevMonthClose":18.8,"prevQuarterClose":17.46,"fiveDayClose":17.98,"twentyDayClose":19.98,"sixtyDayClose":19.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盘后","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754496000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2025-08-25","current":-24.093478,"percent":0.08818,"low":-30.832985,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"high":-1.640852,"avg":-10.791117,"sd":7.187702,"marketCap":6322695243},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-25","current":-24.093478,"twenty":-16.858738,"median":-8.407124,"eighty":-4.826315,"marketCap":6322695243}],"updateTime":1756186927627},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546193842","title":"每日卖空追踪 | 来凯医药-B 06月25日卖空量成交2.1万股，卖空比例为0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546193842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546193842?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 16:30","pubTimestamp":1750840225,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月25日，跌9.14%，卖空量成交2.1万股%，较上一交易日减少92.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625175408a4bd1ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625175408a4bd1ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2546263231","title":"来凯医药-B盘中异动 早盘快速下挫5.08%报18.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546263231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546263231?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 10:13","pubTimestamp":1750817617,"startTime":"0","endTime":"0","summary":"2025年06月25日早盘10时13分，来凯医药-B股票出现异动，股价快速下挫5.08%。截至发稿，该股报18.700港元/股，成交量147.8万股，换手率0.36%，振幅6.60%。资金方面，该股资金流入1184.41万港元，流出1523.19万港元。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.57%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625101337978db7a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625101337978db7a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2546729952","title":"医药行业周专题：减重需求正盛 多方向酝酿破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729952","media":"东方证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546729952?lang=zh_cn&edition=fundamental","pubTime":"2025-06-25 00:00","pubTimestamp":1750780800,"startTime":"0","endTime":"0","summary":"减重市场狂飙，GLP-1RAs 催生新“药王”。25Q1，全球主要GLP-1RAs药物销售额达159.6 亿美元，同比增长47.9%，其中减重领域增速远超降糖领域。25Q1 司美格鲁肽销售额达83.8 亿美元，超过帕博利珠单抗成为新“药王”。近年来，减重领域重磅交易频发，各MNC正完善多靶点分子和口服小分子方向的布局。全球减重领域正快速发展，其中涌现多个重要方向，如：长效制剂、口服制剂、多靶点分子或多靶点联用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625160118a71c9bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625160118a71c9bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","688166","603087","01672","600276","03933"],"gpt_icon":0},{"id":"2545781894","title":"2025年医药行业动态与战略布局：创新药物研发驱动市场增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2545781894","media":"报告大厅","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545781894?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 10:01","pubTimestamp":1750730499,"startTime":"0","endTime":"0","summary":"中国报告大厅网讯，2025年的全球医药产业正经历结构性变革，随着精准医疗、靶向疗法和基因编辑技术的突破性进展，行业竞争焦点从传统仿制药转向创新药领域。以下结合近期医药产业动态与数据，解析重点领域的发展趋势及战略布局方向。这一波动源于其核心药物LAE102的积极进展。数据显示，LAE102在动物模型中有效促进肌肉再生并减少脂肪堆积，为高质量体重控制提供了新方向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624102306978c148a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624102306978c148a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","09939","BK1161","BK1515","BK1574","02105"],"gpt_icon":0},{"id":"2545242762","title":"来凯医药-B高开逾8% 于ADA 2025大会上公布包含LAE102等多项临床研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2545242762","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545242762?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 09:28","pubTimestamp":1750728491,"startTime":"0","endTime":"0","summary":"中信证券发布研报指出，来凯医药-b核心产品LAE102是一款靶向ActRIIA的抗体，在临床前模型中展现出促进肌肉再生及减少脂肪的作用，有望成为实现高质量体重控制的候选药物。目前LAE102正在国内进行MAD研究，并和礼来合作在美国开展临床I期试验。公司的LAE102正处于3期注册性临床研究阶段，用于治疗HR+/HER2-晚期乳腺癌，有望成为全球第二款上市的AKT抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624094024a4ba822b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624094024a4ba822b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2545141096","title":"截至6月24日来凯医药、泰凌微电子、生益电子、华工科技等重点公司的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2545141096","media":"刘翔科技研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545141096?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 21:58","pubTimestamp":1750687107,"startTime":"0","endTime":"0","summary":"截至2025年6月24日，A股及港股市场多家上市公司陆续发布公告。同时，贝壳发布翌日披露报表，披露了自2025年5月以来分阶段实施的股份回购计划。2025年6月20日，公司于纽约证券交易所回购股份92.1万股，成交均价为6.01美元，总金额超过553万美元。年初至今公司已累计回购逾126百万股，占其获授权比例的3.43%。此次回购股份后未被注销，未来可能继续用于员工持股计划或其他用途。公司此前已获中国证监会备案通过，计划在港交所主板挂牌上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623215930a4b93284&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623215930a4b93284&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688591","BK0121","BK0122","688183","BK0143","000988","02105","BK0188","BK0028","BK0072","BK0214","BK0073","BK0076"],"gpt_icon":0},{"id":"2545187754","title":"生物医药：体内CAR-T：全球竞赛已打响，关注云顶新耀和石药集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2545187754","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545187754?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 18:07","pubTimestamp":1750673278,"startTime":"0","endTime":"0","summary":"艾伯维、阿斯利康等多个制药巨头已通过合作/收购布局体内CAR-T赛道。石药集团自主研发的mRNA-LNP的自体CAR-T疗法进入临床，体内CAR-T的布局亦可期待。全球自体CAR-T细胞疗法全球销售额2024年合计超45亿美金，制造过程繁琐、可及性低和价格昂贵的缺点限制其应用。实现体内CAR-T疗法的核心挑战，在于如何将CAR构建体精准、高效且安全地递送至目标T细胞。慢病毒载体可将CAR基因永久整合到宿主T细胞的基因组中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506231808059527dd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506231808059527dd22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZLAB","BK4139","BK4548","688235","BK4230","ONC","CAR","09926","BK4022","BK4531","06160","01672","03681","09688","BK4526","BK4585","01801","02105","LU2488822045.USD","BK4588"],"gpt_icon":0},{"id":"2545062497","title":"每日卖空追踪 | 来凯医药-B 06月23日卖空量成交5000股，卖空比例为0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545062497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545062497?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 16:30","pubTimestamp":1750667428,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月23日，跌9.93%，卖空量成交5000股%，较上一交易日减少68.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623173741a7187579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623173741a7187579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2545245719","title":"来凯医药-B盘中异动 早盘急速跳水5.04%报19.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545245719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545245719?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:32","pubTimestamp":1750642369,"startTime":"0","endTime":"0","summary":"2025年06月23日早盘09时32分，来凯医药-B股票出现异动，股价急速跳水5.04%。截至发稿，该股报19.800港元/股，成交量12.25万股，换手率0.03%，振幅5.13%。资金方面，该股资金流入55.8175万港元，流出164.561万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，药捷安康-B、和铂医药-B、正大企业国际涨幅较大，振幅较大的相关个股有北海康成-B、药捷安康-B、宜明昂科-B，振幅分别为15.15%、9.89%、5.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093249978a8738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623093249978a8738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2545045130","title":"来凯医药-B：LAE102、LAE103及LAE123临床和临床前研究结果在2025年ADA大会上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2545045130","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545045130?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 08:01","pubTimestamp":1750636908,"startTime":"0","endTime":"0","summary":"格隆汇6月23日丨来凯医药-B(02105.HK)宣布：(i)用于治疗肥胖症的LAE102（一种针对Act RI IA的单克隆抗体）的I期单剂量递增(SAD)研究结果；以及(ii)LAE102、LAE103（一种针对ActRIIB的单克隆抗体）及LAE123（一种针对Act RIIA/IIB双靶点的单克隆抗体）作为增肌减脂疗法的临床前研究结果，已于美国糖尿病协会(ADA)第85届科学年会上公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062308020395272c0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062308020395272c0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2544214005","title":"来凯医药-B06月20日主力净流入30.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2544214005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544214005?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 16:15","pubTimestamp":1750407351,"startTime":"0","endTime":"0","summary":"06月20日, 来凯医药-B股价涨6.81%，报收20.85元，成交金额8279.4万元，换手率1.03%，振幅8.76%，量比0.68。来凯医药-B今日主力资金净流入30.4万元，上一交易日主力净流出401.6万元。该股近5个交易日下跌5.19%，主力资金累计净流出3165.9万元；近20日主力资金累计净流出4978.6万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620172724a4b45166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620172724a4b45166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2544915299","title":"【热门行业】中国创新药估值逻辑加速重构 行业或进入2-3年上行期","url":"https://stock-news.laohu8.com/highlight/detail?id=2544915299","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544915299?lang=zh_cn&edition=fundamental","pubTime":"2025-06-19 17:18","pubTimestamp":1750324690,"startTime":"0","endTime":"0","summary":"这只是国产创新药“出海”的缩影。据药智网数据，2020年国产创新药BD交易总金额仅92亿美元，2024年已飙升至523亿美元；2025年仅上半年，交易总额已达455亿美元，首付款超22亿美元。此外，截至今年，超过5,000万美元的预付款交易占总交易量的42%，从2019年的0%和2024年的27%大幅上升。板块估值逻辑正加速重构，投资者情绪由悲转喜。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1960779","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","LU0880133367.SGD","LU1807302812.USD","LU1951186391.HKD","LU1993786604.SGD","IE00B5MMRT66.SGD","IE0008368742.USD","LU0140636845.USD","LU1226287529.USD","BK1583","06978","00013","BK1515","09688","LU1008478684.HKD","LU1152091754.HKD","BK1587","IE00BZ08YT58.USD","LU0501845795.SGD","LU0072913022.USD","LU1152091168.USD","LU1960683339.HKD","01093","IE00BZ08YS42.EUR","LU1226287875.USD","02105","LU1226288170.HKD","SG9999004220.SGD","IE00B031HY20.USD","BK1588","02142","IE00B543WZ88.USD","BK1574","LU2488822045.USD","IE00BZ08YR35.GBP","LU0067412154.USD","02186","LU1226287792.SGD","IE0008369823.USD","LU0326950275.SGD","LU1226288253.USD","BK1521","159992","BK1606"],"gpt_icon":1},{"id":"2544990515","title":"背景资料-要脂肪，不要肌肉制药商竞相寻求下一个减肥突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2544990515","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544990515?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 22:41","pubTimestamp":1750257675,"startTime":"0","endTime":"0","summary":"路透6月18日 - 目前的减肥方法包括改变生活方式、手术以及诺和诺德公司NOVOb.CO的Wegovy和礼来公司LLY.N的Zepbound等流行疗法，这些方法都会导致脂肪和肌肉流失，从而增加跌倒的风险并降低整体力量，这对老年患者尤其有害。以下公司正在开发减肥疗法 ，帮助患者在减重的同时保持或增加肌肉：。再生元 Regeneron公司REGN.O正在对其药物trevogrumab、Wegovy和另一种治疗药物garetosmab进行测试，这项研究由三部分组成，分别针对健康和肥胖的参与者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nL4T3SL11P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","LU2063271972.USD","IE00BK4W5L77.USD","LU1061106388.HKD","IE00B3T34201.USD","VERU","LU1366192091.USD","LU0289739699.SGD","AZN.UK","LU0882574055.USD","LU0823399737.USD","LU0972486137.USD","LU0203345920.USD","LU1003077747.HKD","BK4585","LU0976567544.SGD","SG9999014898.SGD","LU0820561909.HKD","LU0786609619.USD","LLY","LU2602419157.SGD","LU1064131342.USD","LU1019632923.USD","SG9999018857.SGD","LU2091194634.USD","LU1487256676.USD","SG9999017495.SGD","LU0310800379.SGD","LU1084165304.USD","SGXZ99366536.SGD","LU2462157665.USD","LU1868837136.USD","KROS","LU1267930227.SGD","ARWR","LU0957799991.USD","02105","SGXZ31699556.SGD","LU0234572021.USD","LU0266013472.USD","LU0499090636.EUR","LU2357305700.SGD","SRRK","LU0823434740.USD","03165","BHVN","ALT","IE00B4R5TH58.HKD","REGN","ELAB"],"gpt_icon":1},{"id":"2544758379","title":"每日卖空追踪 | 来凯医药-B 06月18日卖空量成交12.7万股，卖空比例为3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544758379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544758379?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 16:30","pubTimestamp":1750235427,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月18日，涨3.83%，卖空量成交12.7万股%，较上一交易日增加93.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618175310a7103fcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618175310a7103fcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2544963212","title":"每日卖空追踪 | 来凯医药-B 06月17日卖空量成交3.5万股，卖空比例为0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544963212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544963212?lang=zh_cn&edition=fundamental","pubTime":"2025-06-17 16:30","pubTimestamp":1750149026,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月17日，跌11.91%，卖空量成交3.5万股%，较上一交易日减少61.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617175018a70e066b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617175018a70e066b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2543673035","title":"每日卖空追踪 | 来凯医药-B 06月16日卖空量成交6.95万股，卖空比例为1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543673035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543673035?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 16:30","pubTimestamp":1750062625,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月16日，涨0.45%，卖空量成交6.95万股%，较上一交易日增加13.01%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616175029a4abcc9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616175029a4abcc9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2543649136","title":"来凯医药-B盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543649136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543649136?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 11:12","pubTimestamp":1750043522,"startTime":"0","endTime":"0","summary":"2025年06月16日早盘11时12分，来凯医药-B股票出现波动，股价大幅拉升5.19%。截至发稿，该股报23.300港元/股，成交量386.9万股，换手率0.95%，振幅7.22%。资金方面，该股资金流入4283.51万港元，流出3792.98万港元。来凯医药-B股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，北海康成-B、帝王国际投资、歌礼制药-B涨幅较大，振幅较大的相关个股有北海康成-B、歌礼制药-B、帝王国际投资，振幅分别为55.38%、18.01%、17.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616111203951e1d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616111203951e1d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2543883966","title":"每日卖空追踪 | 来凯医药-B 06月13日卖空量成交3.75万股，卖空比例为0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543883966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543883966?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 16:30","pubTimestamp":1749803424,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间06月13日，跌3.28%，卖空量成交3.75万股%，较上一交易日减少56.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613174551a4a71f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613174551a4a71f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2543207865","title":"来凯医药-B盘中异动 急速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543207865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543207865?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 10:26","pubTimestamp":1749781583,"startTime":"0","endTime":"0","summary":"2025年06月13日早盘10时26分，来凯医药-B股票出现波动，股价大幅下跌5.02%。截至发稿，该股报21.750港元/股，成交量194.4万股，换手率0.48%，振幅6.77%。来凯医药-B股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，北海康成-B、帝王国际投资、欧康维视生物-B涨幅较大，振幅较大的相关个股有北海康成-B、华领医药-B、帝王国际投资，振幅分别为65.37%、11.99%、11.40%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613102623a4a65acd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613102623a4a65acd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2542174511","title":"6.5亿美元！礼来押注AI平台，开发“增肌”新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2542174511","media":"药时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542174511?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 19:59","pubTimestamp":1749729568,"startTime":"0","endTime":"0","summary":"2025年6月11日，礼来与Juvena Therapeutics达成了一项超6.5亿美元的合作协议，双方将共同开发和商业化多款增肌药物。早在2023年，礼来就以高达19.2亿美元收购了Versanis Bio，获得了一款减脂增肌候选药物ActRII单抗Bimagrumab。对于礼来而言，“AI+内分泌疗法”不失为增肌药物研发的另一条突破口，并以此拓宽研发路径。并且，肌肉会随着年龄的增加而逐渐流失。于此同时，礼来的替尔泊肽更是以惊人的速度快速放量，2024年销售额为164.458亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612202613a7054d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612202613a7054d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","LLY","MRK","BK1161"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":194,"code":"91000000","status":"200"}]}}